Report Categories
View AllRecent Articles
View All
PHVS Pharvaris NV reports wider than expected Q4 2025 loss even as shares rise nearly two percent on positive investor sentiment
Why Columbia COLM ability to innovate sets it apart 020 20260508
The capital expenditure plan at POSCO PKX POSCO Posts Deep Loss 1717 Negative EPS Miss
What The Beauty SKIN segment performance reveals Q1 2026 Better Than Expected